ABSTRACT
Conclusions: Vietnamese pathologists would benefit from hematopathology training or opportunities to consult with hematopathologists in the United States. Expert hematopathology consultation services are currently unavailable within Vietnam, as postgraduate training for laboratory physicians consists of residency training in anatomic pathology only. Limitations in the quality of histopathology and immunohistochemistry could impose a barrier to success of efforts to improve hematopathology diagnosis. Implementation of a histopathology and immunohistochemistry quality improvement program might overcome this limitation.
In his introduction to the 2016 update for the World Health Organization (WHO) classification of hematopoietic neoplasms, the associate editor for the journal Blood describes "remarkable progress" in the understanding and diagnosis of leukemias and lymphomas. Recent diagnostic innovations allow for improved options for therapies, including curative treatments for these diseases. 1 The revised diagnostic terminology allowing for more specific and directed therapies requires the pathologist and the laboratory to be responsible for correlation of clinical and morphologic findings and, in some cases, ancillary studies, including immunophenotyping, cytogenetics, and molecular diagnostic testing. 2, 3 It has been predicted that cancer will increase as much as 70% by 2032, with most of these cases being in Asia, Central and South America, and Africa. Although patients in developing countries might benefit from new treatment protocols, it is not possible to effectively treat any malignancy without specific and accurate diagnoses. There is good evidence of underinvestment in both pathology education and laboratory development in low-and medium-income countries; this could be a barrier to diagnostic accuracy. 4 However, programs have overcome these barriers. 5 Medical education for Vietnamese pathologists is similar to that in the United States, but it lacks opportunities for advanced or specialized training. Vietnamese high school graduates who have passed a basic science examination can be accepted to and attend a 6-year medical school. Postgraduate residency for pathologists consists of 3 years of training in anatomic pathology with
© American Society for Clinical Pathology
Dayton et al / OppOrtunities tO imprOve HematOpatHOlOgy DiagnOsis fOr vietnam patHOlOgists certification by a written examination, a written thesis, and an oral interview. There are no subspecialty training programs in Vietnam for lymph node pathology, bone marrow pathology, flow cytometric immunophenotyping, cytogenetics, or molecular diagnostics. Clinical laboratory training is typically part of a PhD program in laboratory science. There are no requirements for continuing medical education. This absence of structured training and experience in correlating hematopathology tissue histology, including bone marrow core biopsy specimens, with other clinical and laboratory findings led to a request by academic pathologists in Ho Chi Minh City, Vietnam (HCMC VN), for help from US pathologists.
In 2015, two American Board of Pathology-certified hematopathologists from the United States presented a single educational workshop on using the WHO 2008 classification system for hematopathology diagnosis in HCMC VN. 6 At the conclusion of the workshop, it was the impression and recommendation of the US pathologists that their Vietnamese counterparts would benefit from continued opportunities to review their cases with hematopathologists from the United States. When invited to return to Vietnam for follow-up workshops in 2016, the US hematopathologists sought to gather information needed to initiate the process of exploring such opportunities.
Materials and Methods
Public and private donors from the United States and Vietnam planned, funded, and organized site visits and workshops at what they believed were the three major academic oncology hospitals in the north and south of Vietnam. Prior to traveling to Vietnam, the US pathologists were sent diagnostic slides and clinical information to review from each Vietnam hospital for up to 11 patient cases considered challenging by the Vietnamese physicians. For some cases, paraffin tissue blocks were also sent, allowing the US pathologists to recut and restain as needed as well as to perform additional testing if deemed appropriate. Repeat immunohistochemistry was performed by Pensacola Pathologists Laboratory (Pensacola, FL), using an automated staining system with standard commercial reagents for immunostains (cyclin D1 and CD30) and Epstein Barr virus (EBER DNP) probes.
Upon arrival in Vietnam, the team of US pathologists was permitted to tour all areas of each of the three hospital laboratories and to collect data such as photographs and documentation of laboratory equipment, procedures, and protocols.
At each site visit, the workshop was introduced with a lecture detailing the 2016 updates to the WHO classification of lymphomas. Algorithms for lymphoma subclassification, beginning with microscopic morphology and incorporating ancillary studies including immunohistochemistry, were presented. 1, 2 The cases submitted by each hospital were shown in lecture format at the submitting hospital, with that site's pathologists, clinicians, trainees, and students in attendance. For each case, photomicrographs of H&E-stained and immunostained sections provided by the institution were projected with a detailed discussion of the differential diagnosis and recommended algorithms for selection of immunostains and other ancillary studies. Each case presentation concluded with the preferred diagnosis of the US-trained hematopathologists supplemented, when available, by photomicrographs of immunostained sections prepared by a US laboratory. When time permitted, the US pathologists also reviewed current cases at each laboratory with that institution's pathologists and trainees.
Results
Existing equipment for the three hospital laboratories is listed in ❚Table 1❚. All have automated systems for tissue fixation and routine staining. Two of the hospitals have automated equipment for performing immunoperoxidase stains. One has in-house capability for flow cytometric immunophenotyping. One has equipment and procedures for in-house molecular diagnostic testing. One has the equipment for scanning tissue-mounted glass slides, but it was observed that this piece of equipment was not operational at the time of the visit.
Comparison of Vietnam vs US tissue diagnoses is summarized in ❚Table 2❚ and detailed in ❚Table 3❚, ❚Table 4❚, and ❚Table 5❚. Complete diagnostic agreement was observed in less than half of the cases, with most of both major and minor discrepancies attributable to limitations in the quality of slide preparation and immunostains. Decision making regarding algorithms for assessing and addressing immunostain failure became a part of the discussion at each site. An example of improved diagnostic accuracy aided by repeat immunostaining is illustrated in ❚Image 1❚.
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Discussion
It is not possible to effectively treat cancer without specific and accurate diagnoses. The Vietnamese government health system has made cancer treatment protocols for leukemias and lymphomas resembling those used in the United States available to their patients, making it incumbent on their pathologists to optimize their diagnostic accuracy to the level of developed countries.
It was our observation that barriers to diagnostic accuracy for the limited number of leukemia and lymphoma cases reviewed for this report include suboptimal tissue processing and staining. A possible explanation for this deficiency could be the absence of uniform national standards in that country for histotechnology education and certification, as well as a lack of uniform standards for laboratory accreditation and quality. High school graduates can train to become histotechnologists in Vietnam by working for 4 years under a senior histotechnologist in a hospital laboratory. They can then become certified with a written examination. There are no continuing education requirements for Vietnamese histotechnologists and no formal training or certification opportunities in country for immunohistochemistry. Issues similar to those described here have been addressed in other resource-limited countries by providing in-country workshops and technical assistance provided by credentialed laboratory professionals.
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A lesser but observable limitation to diagnostic accuracy was lack of experience by the Vietnamese pathologists in handling complex correlations of clinical, morphologic, and laboratory information required for many hematopathology diagnoses, particularly in the setting of less than adequate histology. Vietnam's pathology residency training is limited to anatomic pathology. No opportunities for subspecialty training in hematopathology are available in Vietnam, and there are no requirements for continuing medical education. The option of postgraduate medical education in the United States for Vietnamese physicians presents language, academic, financial, and political obstacles. If training a core group of Vietnamese hematopathologists in accredited US programs is not feasible, other options need to be considered.
A program of hematopathology training workshops similar to the one described in this article could bring hematopathology education to Vietnam. Although diagnostic algorithms based on the 2016 WHO classification of hematopoietic neoplasms were part of the educational workshops presented at each institution in this report, there are no ongoing hematopathology educational opportunities in Vietnam or expert consultation service to reinforce such case-based learning. Consistent workshops similar to those described here could be the basis for future Vietnam hematopathology education and diagnostic quality improvement. This option would require a significant time and travel commitment on the part of trained expert laboratory physicians from the United States or other developed countries. There are financial and logistical barriers to organizing a regular schedule of workshops. Lack of a national requirement for continuing education for Vietnamese laboratory physicians might limit funding and attendance.
Recent publications in the medical literature have described telemedicine programs for cancer diagnosis in sub-Saharan Africa, despite the fact that specific treatment protocols are not available in those regions. 8 Innovations in digital imaging technology have provided an opportunity for pathologists in the United States to assist their resource-limited colleagues by using telemedicine. In addition to the advantage of scanned pathology slides with interpretive software allowing for real-time expert consultation, a database of digital scans of hematopathology cases could be used for future education and research. Notably, this option requires capital investment in slide-scanning equipment, interpretive software, consistently accessible internet, and a dedicated server with the capacity to store large files. There must be a willingness on the part of US pathologists to incorporate ongoing real-time telepathology into their consultation service. Implementation of slide-scanning technology and file transfer would require a trained laboratory informatics specialist to visit each of the target hospitals to assess technology, infrastructure, and the capacity for troubleshooting technical issues as they arise. Language barriers could create an obstacle to clear communication of accurate diagnoses. Investment of financial, human, and infrastructure resources has been made in Vietnam for facilitation of telemedicine diagnosis in other areas of medicine but not, as yet, in diagnostic pathology.
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Conclusions
Vietnamese pathologists would benefit from an opportunity to improve quality and consistency of hematopathology diagnoses at cancer hospitals in their country. Options for improved hematopathology education for Vietnam pathologists might include a continuing program of in-country workshops provided by US hematopathologists. A telepathology program would allow for more frequent access to US experience and expertise than periodic workshops. Limitations in the quality of histopathology and immunohistochemistry could impose a significant barrier to success of such programs. These limitations could be overcome by providing in-country histopathology and immunohistochemistry training by US volunteers. A continued program of regular hematopathology workshop presentations in major Vietnam cities would be beneficial. Such workshops require financial and logistical support in addition to committed hematopathologists willing to travel regularly to Vietnam. Telepathology could bring together US and Vietnam pathologists without such logistical and travel burdens. Notably, there are numerous obstacles to successful implementation of a telepathology program, including, but not limited to, the investment required for purchase or leasing of slide-scanning equipment along with purchase or solicitation of donating interpretive software, the work of skilled informatics and technology professionals, and computer servers required for this strategy. If these obstacles could be overcome, telemedicine between US and Vietnam pathologists could provide an opportunity for education, research, and quality improvement for cancer diagnoses in both countries. 
